Emilio Bria

15.6k citations
392 papers · 7.1k indexed · 1 hit paper · h-index 46

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • HER2/EGFR in Cancer Research
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • Lung Cancer Research Studies 63
    • Cancer Treatment and Pharmacology 56
    • Colorectal Cancer Treatments and Studies 49
    • Cancer Immunotherapy and Biomarkers 46
    • Cancer Genomics and Diagnostics 54
    • Breast Cancer Treatment Studies 44

Emilio Bria

367 papers receiving 7.0k citations

Hit Papers

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 2015 · 375 citations
3752015202620182022100200300

Peers

Emilio Bria
Comparison fields: 5 of 137
  • Oncology 4.0k
  • Cancer Research 1.5k
  • Pulmonary and Respiratory Medicine 2.8k
  • Immunology 618
  • Pathology and Forensic Medicine 481
Replace Boštjan Šeruga with:
Boštjan Šeruga Canada
Andrew Hendifar United States
Thomas Muley Germany
Judith R. Kroep Netherlands
Antônio Rossi Italy
Martin J. Edelman United States
Lianchun Xiao United States
Naureen Starling United Kingdom
Sylvie Rottey Belgium
Rossana Berardi Italy
Emilio Bria relative to Boštjan Šeruga Canada Boštjan Šeruga's profile →
Citations per field
00.5×1.5×
Boštjan Šeruga · 1×
Citations per year

Countries citing papers authored by Emilio Bria

Since Specialization
Citations

This map shows the geographic impact of Emilio Bria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio Bria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio Bria more than expected).

Fields of papers citing papers by Emilio Bria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio Bria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio Bria. The network helps show where Emilio Bria may publish in the future.

Co-authors

The 25 scholars most cited alongside Emilio Bria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emilio Bria Line = papers co-authored together Emilio Bria links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20243
3 20240
4 20241
5 20245
6 20244
7 202314
8 20231
9 20232
10 20234
11 202219
12 202225
13 20224
14 202210
15 202114
16 202063
17 202057
18 201812
19 201836
20 201838

About Emilio Bria

Emilio Bria is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Microbiology and Hepatology, having authored 392 papers that have together received 7.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (117 papers), Lung Cancer Research Studies (63 papers), Cancer Treatment and Pharmacology (56 papers), Cancer Genomics and Diagnostics (54 papers), Colorectal Cancer Treatments and Studies (49 papers), Cancer Immunotherapy and Biomarkers (46 papers), Breast Cancer Treatment Studies (44 papers) and Lung Cancer Diagnosis and Treatment (43 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (2.8k citations), Immunology (618 citations) and Pathology and Forensic Medicine (481 citations). Emilio Bria has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Giampaolo Tortora, Michèle Milella, Sara Pilotto, Diana Giannarelli, Francesco Cognetti, Isabella Sperduti, Federica Cuppone, E. Terzoli, Luisa Carbognin and Paolo Carlini. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, Critical Reviews in Oncology/Hematology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026